Senior Director, Acquisitions & Divestitures (A&D) Finance, Orthopedics

At Johnson & Johnson,we believe health is everything.

Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.Learn more at jnj.com

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world.

We provide an inclusive work environment where each person is considered as an individual.

At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:
Finance

Job Sub Function:
Treasury

Job Category:
Professional

All Job Posting Locations:
New Brunswick (Any City), Palm Beach Gardens, Florida, United States of America, Raynham, Massachusetts, United States of America, Warsaw, Indiana, United States of America, West Chester, Pennsylvania, United States of America

Job Description:

DePuy Synthes is currently recruiting for a Senior Director, Acquisitions & Divestitures (A&D) Finance to ideally be located in Raynham, MA.

The Corporate A&D Finance team is seeking a seasoned, strategic, and influential Senior Director to serve as the enterprise finance thought partner on portfolio shaping and capital deployment decisions across our sectors (Pharmaceuticals and Medical Technologies).

This leader will set the financial point of view behind DePuy Synthes's acquisitions, partnerships, and divestitures, determining how each transaction fits the enterprise strategy, creates sustainable long-term value, and aligns with capital allocation priorities.

The Senior Director will partner with corporate and sector executives, Business Development, the A&D Community of Practice, and external advisors to establish valuation frameworks, challenge key assumptions, and deliver clear, decision-ready recommendations to the most senior leaders of the company (GOC, EC/MC, and Board of Directors).

Johnson & Johnson announced plans to separate our Orthopedics business to establish a standalone orthopedics company, operating as DePuy Synthes.

The process of the planned separation is anticipated to be completed within 18 to 24 months, subject to legal requirements, including consultation with works councils and other employee representative bodies, as may be required, regulatory approvals and other customary conditions and approvals.

Should you accept this position, it is anticipated that, following conclusion of the transaction, you would be an employee of DePuy Synthes and your employment would be governed by DePuy Synthes employment processes, programs, policies, and benefit plans.

In that case, details of any planned changes would be provided to you by DePuy Synthes at an appropriate time and subj...